CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation
Sponsor: University Hospital, Antwerp
Terminated
lack of resources (personnel and budget)
Other terminated trials from University Hospital, Antwerp
A observational or N/A phase clinical study on Lung Transplant Failure and Rejection and Primary Graft Dysfunction, this trial is terminated or withdrawn. The trial is conducted by University Hospital, Antwerp and has accumulated 7 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jun 2024 — Jul 2024 [monthly]
Terminated
Status: Recruiting → Terminated
-
Dec 2021 — Jun 2024 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
▶ Show 2 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Oct 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Antwerp
For direct contact, visit the study record on ClinicalTrials.gov .